Residency Research Symposium

Wednesday, May 5

Poster Presentations, 11:00 am-1:00 pm
(Medical Education, QI, Clinical)  Meeting ID: 945 4990 9711  |  Passcode: 261271   

Thursday, May 6

Oral Speakers, 1:00-2:30 pm  |  Meeting ID: 977 3312 6290  |  Passcode: 081700

  • Thomas Bolig, Strain-specific detection of burkholderia cepacia complex in cystic fibrosis sputum: concordance between real-time metagenomics and 16s RRNA gene sequencing
  • Chelsea Meloche, Post-discharge readmission and survival after percutaneous coronary intervention among patients with a history of recent gastrointestinal bleeding: insights from the blue cross blue shield of Michigan cardiovascular consortium 
  • Amy Ludwig, Asthma is associated with an increased risk of poor outcomes in hospitalized patients with COVID-19  
  • Devvrat Malhotra, End-of-life care attitudes of seniors in Delhi, India: importance of community and spirituality  
  • Sarah Uttal, Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis
  • Brian Yagi, Association of health insurance literacy with health care utilization: a systematic review  
  • Sang Gune Yoo, Marijuana use and in-hospital outcomes after percutaneous coronary intervention in Michigan, united states  
  • Mary Finta, Phq-9 parallels: the use of a neurodegenerative subscore in older adults with dementia  

Poster Presentation, 2:30-4:00 pm - ROOM 1
(Cardiology, Renal, and Pulmonology)  |  Meeting ID: 927 3373 5005  |  Passcode: 845963     

Poster Presentation, 2:30-4:00 pm - ROOM 2
(Pulmonology and Critical Care)  Meeting ID: 995 2085 5035   Passcode: 356068    

Poster Presentation,  2:30-4:00 pm - ROOM 3
(Gastroenterology)   Meeting ID: 975 4677 4312   Passcode: 585286   

  • Noah Boton, Evaluation of persistent diarrhea and recurrence following fecal microbiota transplantation for recurrent clostridioides difficile infection 
  • Michael Dias, Tofacitinib for hospitalized patients with severe acute ulcerative colitis: a retrospective case control series  
  • Jacob DiBattista, Comparison of scoring systems for diagnosing hepatic steatosis in the absence of imaging using real-world health data  
  • Mehwish Ahmed, Crohn’s disease, anxiety and depression, and baseline c-reactive protein as risk factors for development of irritable bowel -like symptoms in inflammatory bowel disease
  • Jeffrey Gibbs, The rate of successful extubation in mechanically ventilated critically ill intubated patients with cirrhosis and the impact of early rifaximin therapy 
  • Stephanie Owyang, A multivariable model for increased level of care on discharge in admitted patients diagnosed with clostridium difficile infection*
  • Linnea Swanson, Liver injury in patients with advanced cutaneous squamous cell carcinoma receiving cemiplimab immunotherapy 
  • Andrew Brown, Transarterial chemoembolization versus transarterial radioembolization for patients with hepatocellular carcinoma: a meta-analysis 
  • Sagar Joshi, Variability in formulation, shelf-life, and compounded budesonide for eosinophilic esophagitis – a survey of compounding pharmacy practices 
  • Janson Jacob, Patient perceptions on transition from clinic-based infusions to home-based infusions for inflammatory bowel disease patients during the covid-19 pandemic: a qualitative quality improvement study 
  • Kara Leventhal, Use of icd-10 codes to identify cases of idiosyncratic drug-induced liver injury in the electronic medical record  

Poster Presentation, 2:30-4:00 pm - ROOM 4
(Hematology/Oncology)   Meeting ID: 986 2973 8331   Passcode: 242144  

  • Cameron Wood, Patterns of IRAE during first line pembrolizumab for NSCLC: incidence, risk factors, and impact on clinical outcome  
  • Victoria Wytiaz, Variations in objective knowledge among decision support persons of patients with early stage breast cancer
  • Cindy Jiang, Giant cell tumor of bone: effect of longer dosing intervals of denosumab on tumor control and bone related complications
  • Shihan Khan, Significance of fever events detected by high-frequency temperature monitoring but missed by clinical standard‑of-care during treatment of hematological malignancies 
  • Stephen Maurer, Infectious complications after second allogeneic hematopoietic cell transplant (allo-hct) in adult patients with hematological malignancies  
  • Virginia Falvello, Factors associated with documentation of driving recommendations in patients with breast cancer and brain metastases
  • Urvashi Mitbander, Clinical outcomes after utilization of novel prostate-specific membrane antigen targeted positron emission tomography in patients with biochemical recurrent prostate cancer 
  • Joseph Park, Immunotherapy in metastatic sarcomatoid renal cell carcinoma: a single institution experience  

Poster Presentation, 2:30-4:00 pm - ROOM 5
(General Medicine, QI, Health Services)   Meeting ID: 923 2495 3388   Passcode: 288482 

Friday, May 7

Plenary Speakers

  • Stephanie Spehar, Race and outcomes after contemporary percutaneous coronary intervention: insights from the blue cross blue shield of Michigan cardiovascular consortium
  • Jonathan Weiss,  Specific expression of plk-1 in nodular lymphocyte predominant hodgkin lymphoma correlates with disease stage, and selective plk-1 inhibition with volasertib may constitute a viable therapeutic alternative
  • Rafey Feroze, Diagnostic and prognostic value of soluble urokinase plasminogen activator receptor (supar) in cardiac ischemia